3 August, 2021

Covid-19 is a new systemic risk. What are the implications for governance?

A long-term perspective—and a grounding in ethics and values more generally—should guide both investor and board responses.

Image: Lightspring/Shutterstock

Covid-19 emerged in December 2019 and has quickly become a global crisis that threatens the health of individuals and the welfare of societies on a vast scale, including its impact on global economic activity and growth. The ongoing—and profound—uncertainties create great challenges for corporates, their boards and their investors as they contemplate how best to navigate these difficult and dynamic times. Covid-19 clearly meets the International Corporate Governance Network’s (IGCN) criteria of a systemic risk as put forward in ICGN’s Guidance on Investor Fiduciary Duties: “The nature of systemic risk is that it builds over ti

Want to read more? Register with a few details to continue reading this article or log in.

For thoughtful journalism, expert insights on corporate governance and an extensive library of reports, guides and tools to help boards and directors navigate the complexities of their roles, subscribe to Board Agenda

board effectiveness, coronavirus, corporate governance, crisis management, investors, risk, risk management, strategy